Title |
Hepatitis B virus X gene and hepatocarcinogenesis
|
---|---|
Published in |
Journal of Gastroenterology, June 2011
|
DOI | 10.1007/s00535-011-0415-9 |
Pubmed ID | |
Authors |
Sue-Ann Ng, Caroline Lee |
Abstract |
Chronic hepatitis B virus (HBV) infection has been identified as a major risk factor in hepatocellular carcinoma (HCC), which is one of the most common cancers worldwide. The pathogenesis of HBV-mediated hepatocarcinogenesis is, however, incompletely understood. Evidence suggests that the HBV X protein (HBx) plays a crucial role in HCC development. HBx is a multifunctional regulator that modulates transcription, signal transduction, cell cycle progression, apoptosis, protein degradation pathways, and genetic stability through interaction with host factors. This review describes the current state of knowledge of the molecular pathogenesis of HBV-induced HCC, with a focus on the role of HBx in hepatocarcinogenesis. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 1 | 1% |
South Africa | 1 | 1% |
Russia | 1 | 1% |
Spain | 1 | 1% |
United States | 1 | 1% |
Unknown | 86 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 24 | 26% |
Student > Ph. D. Student | 13 | 14% |
Student > Master | 7 | 8% |
Student > Bachelor | 6 | 7% |
Student > Doctoral Student | 4 | 4% |
Other | 18 | 20% |
Unknown | 19 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 30 | 33% |
Medicine and Dentistry | 15 | 16% |
Biochemistry, Genetics and Molecular Biology | 13 | 14% |
Unspecified | 4 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
Other | 9 | 10% |
Unknown | 18 | 20% |